This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (27)  • Contact me when this article is cited  Related Content  • Related letters  • Related article  • Similar articles in JAMA  Topic Collections  • Journalology/ Peer Review/ Authorship  • Conflict of Interest  • Alert me on articles by topic

Phil B. Fontanarosa, MD, MBA; Annette Flanagin, RN, MA; Catherine D. DeAngelis, MD, MPH

JAMA. 2005;294:110-111.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Research studies in biomedical journals are increasingly scrutinized, not only for their scientific findings and clinical and public health implications, but also because of concerns related to conflicts of interest of investigators¹ and concerns about misleading reporting of industry-sponsored research.² The perception that conflicts of interest or financial concerns may have potentially detrimental effects on medical science has prompted medical journals to critically examine and more vigorously enforce policies for disclosure of potential conflicts and for reporting of relationships with industry.³

The need for transparency in reporting the financial conflicts of interest of authors and the relationships between investigators and funding sources has never been greater and is essential to help maintain confidence and trust in the scientific integrity of medical research articles. In this editorial, we review and update our policies for authors reporting conflicts . . . [Full Text of this Article]

Author Affiliations: Dr Fontanarosa is Executive Deputy Editor (phil.fontanarosa@jama-archives.org), Ms Flanagin is Managing Deputy Editor, and Dr DeAngelis is Editor-in-Chief, JAMA.

RELATED LETTERS

Conflicts of Interest and Independent Data Analysis in Industry-Funded Studies
Caroline J. Loew
JAMA. 2005;294(20):2575.
EXTRACT | FULL TEXT  

Conflicts of Interest and Independent Data Analysis in Industry-Funded Studies
Geert Molenberghs, Peter Imrey, and Christiana Drake
JAMA. 2005;294(20):2575-2576.
EXTRACT | FULL TEXT  

Conflicts of Interest and Independent Data Analysis in Industry-Funded Studies—Reply
Phil B. Fontanarosa and Catherine D. DeAngelis
JAMA. 2005;294(20):2576-2577.
EXTRACT | FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies—Reply
Catherine D. DeAngelis and Phil B. Fontanarosa
JAMA. 2008;300(8):905-906.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Instructions for Authors
JAMA. 2005;294(1):119-127.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies--Reply
DeAngelis and Fontanarosa
JAMA 2008;300:905-906.
FULL TEXT  

Impugning the Integrity of Medical Science: The Adverse Effects of Industry Influence
DeAngelis and Fontanarosa
JAMA 2008;299:1833-1835.
FULL TEXT  

Publication of Clinical Trials in JAMA: Information for Authors
Fontanarosa and DeAngelis
JAMA 2008;299:95-96.
FULL TEXT  

Reproducible Research: Moving toward Research the Public Can Really Trust
Laine et al.
ANN INTERN MED 2007;146:450-453.
ABSTRACT | FULL TEXT  

Declaration of patent applications as financial interests: a survey of practice among authors of papers on molecular biology in Nature.
Mayer
J. Med. Ethics 2006;32:658-661.
ABSTRACT | FULL TEXT  

Response to Letters by Whiteley et al and Goldstein et al
Weintraub
Stroke 2006;37:2664-2665.
FULL TEXT  

The Influence of Money on Medical Science
DeAngelis
JAMA 2006;296:996-998.
FULL TEXT  

Unreported Financial Disclosures in a Study of Migraine and Cardiovascular Disease--Reply
DeAngelis and Fontanarosa
JAMA 2006;296:654-654.
FULL TEXT  

Update on JAMA's Conflict of Interest Policy.
Flanagin et al.
JAMA 2006;296:220-221.
FULL TEXT  

President's Page: American College of Cardiology Fellowship: Where Ideals and Personal Responsibility Intersect
Nissen and President, American College of Cardiology
J Am Coll Cardiol 2006;47:1901-1903.
FULL TEXT  

Thank You, JAMA Peer Reviewers and Authors
DeAngelis and Fontanarosa
JAMA 2006;295:1171-1172.
FULL TEXT  

Are journals doing enough to prevent fraudulent publication?
CMAJ 2006;174:431-431.
FULL TEXT  

Les journaux font-ils assez d'efforts pour prevenir la publication frauduleuse?
CMAJ 2006;174:433-433.
FULL TEXT  

On bias and transparency in the development of influential recommendations
Laupacis
CMAJ 2006;174:335-336.
FULL TEXT  

JAMA's policy on industry sponsored studies
Fontanarosa and DeAngelis
BMJ 2006;332:177-177.
FULL TEXT  

Instructions for Authors
JAMA 2006;295:103-111.
FULL TEXT  

Extra scrutiny for industry funded trials
Rothman and Evans
BMJ 2005;331:1350-1351.
FULL TEXT  

Conflicts of Interest and Independent Data Analysis in Industry-Funded Studies
Loew
JAMA 2005;294:2575-2575.
FULL TEXT  

Conflicts of Interest and Independent Data Analysis in Industry-Funded Studies--Reply
Fontanarosa and DeAngelis
JAMA 2005;294:2576-2577.
FULL TEXT  

Conflicts of Interest and Independent Data Analysis in Industry-Funded Studies
Molenberghs et al.
JAMA 2005;294:2575-2576.
FULL TEXT  

Adding Value to Evidence-Based Clinical Guidelines
O'Connor
JAMA 2005;294:741-743.
FULL TEXT  

Instructions for Authors
JAMA 2005;294:119-127.
FULL TEXT